Open access · CC-BY
via OpenAlex
Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse
Lloye M. Dillon, Aline Hida, Sofía García, Tomas A. Prolla, Carlos T. Moraes
PLoS ONE · 2012 · ▲ 44 citations
Abstract
Pharmacological agents, such as bezafibrate, that activate peroxisome proliferator-activated receptors (PPARs) and PPAR γ coactivator-1α (PGC-1α) pathways have been shown to improve mitochondrial function and energy metabolism. The mitochondrial DNA (mtDNA) mutator mouse is a mouse model of aging that harbors a proofreading-deficient mtDNA polymerase γ. These mice develop many features of premature aging including hair loss, anemia, osteoporosis, sarcopenia and decreased lifespan. They also have increased mtDNA mutations and marked mitochondrial dysfunction(definition). We found that mutator mice treated with bezafibrate for 8-months had delayed hair loss and improved skin and spleen aging-like phenotypes. Although we observed an increase in markers of fatty acid oxidation in these tissues, we did not detect a generalized increase in mitochondrial markers. On the other hand, there were no improvements in muscle function or lifespan of the mutator mouse, which we attributed to the rodent-specific hepatomegaly associated with fibrate treatment. These results showed that despite its secondary effects in rodent's liver, bezafibrate was able to improve some of the aging phenotypes in the mutator mouse. Because the associated hepatomegaly is not observed in primates, long-term bezafibrate treatment in humans could have beneficial effects on tissues undergoing chronic bioenergetic-related degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0044335
- Canonical
- link ↗
- Fetched
- 2026-06-06 MST
Cite this
APA
Dillon, L.M., Hida, A., García, S., Prolla, T.A., & Moraes, C.T. (2012). Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0044335
Vancouver
Dillon LM, Hida A, García S, Prolla TA, Moraes CT. Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse. PLoS ONE. 2012. doi:10.1371/journal.pone.0044335.
BibTeX
@article{lloye2012LongTe,
title = {Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse},
author = {Lloye M. Dillon and Aline Hida and Sofía García and Tomas A. Prolla and Carlos T. Moraes},
journal = {PLoS ONE},
year = {2012},
doi = {10.1371/journal.pone.0044335},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Autophagy 2024
Open access · CC-BY
Aging STINGs: mitophagy at the crossroads of neuroinflammation
Antioxidants 2026
Open access · CC-BY
Fisetin Attenuates D-Gal-Induced Ovarian Aging by Modulating Mitophagy via the AMPK/mTOR Pathway
Pharmaceuticals 2021
Open access · CC-BY
Nrf2/ARE Activators Improve Memory in Aged Mice via Maintaining of Mitochondrial Quality Control of Brain and the Modulation of Gut Microbiome
Proceedings of the National Academy of Sciences 2005
Preprint · OA
Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production
Theranostics 2026
Open access · CC-BY
ARG2 drives osteoblast senescence by repressing mitophagy via the IκB–NF-κB–TXN2 signaling axis: implications for age-associated osteoporosis
Clinical Therapeutics 2015
Citation only